Posted in | News

Coherent Debuts Libra-HE+ Single-Stage Ultrafast Amplifier

Coherent, Inc. (Santa Clara, CA) has expanded their family of ultrafast laser amplifiers with the new Libra-HE+, which is now the highest power one-box, single-stage ultrafast amplifier available. This amplifier delivers pulse energy > 5 mJ (at a 1 kHz repetition rate) with a choice of pulsewidths: <40 fs or 100fs.

Coherent Libra-HE+

Together with its superior beam quality and stable output, this makes the Libra-HE+ an ideal pump for tunable optical parametric amplifiers (OPAs) such as Coherent’s OperA Solo. This combination can serve as a simple and compact tunable source for ultrafast studies in photochemistry, solid state research and biology. And its rugged stability and operational simplicity means it is particularly well-suited for use as a shared resource in a multi-user facility.

As with other Coherent amplifier products, the unique geometry of the titanium:sapphire gain crystal in the new Libra-HE+ enables water-only cooling which simplifies operation and lowers the cost of ownership as compared to thermo-electric or cryogenic cooling of the crystal. And, the use of a single regenerative amplifier stage in the Libra-HE+ minimizes both overall size and system cost, while resulting in superior output beam quality (M2 < 1.3) and energy stability (<0.5% rms).

Founded in 1966, Coherent, Inc. is a world leader in providing photonics based solutions to the commercial and scientific research markets, and is part of the Standard & Poor’s SmallCap 600 Index and the Russell 2000. Please direct any questions about this press release to Steve Butcher, Director of Marketing, Research Laser Systems business unit, at 408-764-4639. For more information about Coherent, including product and financial updates, visit our website at http://www.Coherent.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.